Jianqing Xu Selected Research

Jianqing Xu Research Topics

Disease

54	Infections 04/2024 - 03/2002
22	Neoplasms (Cancer) 07/2023 - 09/2010
20	COVID-19 03/2024 - 01/2020
19	Human Influenza (Influenza) 03/2024 - 11/2006
15	Vaccinia 08/2021 - 05/2003
8	Virus Diseases (Viral Diseases) 03/2024 - 01/2016
8	Inflammation (Inflammations) 11/2021 - 01/2012
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 01/2005
5	Tuberculosis (Tuberculoses) 04/2024 - 01/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 04/2017
4	Persistent Infection 11/2017 - 01/2005
3	Hypoxia (Hypoxemia) 01/2023 - 10/2020
3	HIV Infections (HIV Infection) 09/2022 - 01/2018
3	Pneumonia (Pneumonitis) 11/2021 - 01/2014
3	Communicable Diseases (Infectious Diseases) 01/2021 - 09/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2014
3	Zika Virus Infection 01/2020 - 08/2017
2	Pulmonary Tuberculosis 04/2024 - 11/2023
2	Reinfection 12/2023 - 01/2022
2	Bites and Stings (Sting) 01/2023 - 01/2022
2	Rabies (Hydrophobia) 01/2023 - 01/2022
2	Experimental Melanoma 01/2023 - 07/2015
2	Disease Progression 01/2021 - 02/2016
2	Cough 01/2021 - 08/2020
2	Astrocytoma (Pilocytic Astrocytoma) 01/2020 - 04/2014
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2016
2	Influenza in Birds (Avian Flu) 09/2016 - 01/2012
2	Glioma (Gliomas) 04/2014 - 01/2014
1	Pain (Aches) 01/2024
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2023
1	Post-Acute COVID-19 Syndrome 12/2023
1	Fatigue 12/2023
1	Pancreatitis 11/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2023
1	Hypoparathyroidism 05/2023
1	Secondary Hyperparathyroidism 05/2023

Drug/Important Bio-Agent (IBA)

32	VaccinesIBA 03/2024 - 01/2005
19	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2008
15	AntigensIBA 01/2023 - 05/2003
12	CytokinesIBA 01/2024 - 01/2014
11	Antiviral Agents (Antivirals)IBA 03/2024 - 09/2007
11	AntibodiesIBA 01/2022 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2016
7	Neutralizing AntibodiesIBA 03/2024 - 11/2012
7	Messenger RNA (mRNA)IBA 01/2024 - 01/2017
7	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 11/2006
7	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2016
5	RNA (Ribonucleic Acid)IBA 04/2024 - 08/2017
5	Immunoglobulin G (IgG)IBA 09/2022 - 12/2007
5	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 12/2013
5	Interferon Type IIBA 01/2022 - 08/2017
5	Peptides (Polypeptides)IBA 01/2018 - 05/2003
5	DNA VaccinesIBA 12/2017 - 06/2007
4	Chimeric Antigen ReceptorsIBA 01/2023 - 10/2020
4	InterferonsIBA 01/2022 - 01/2014
4	Monoclonal AntibodiesIBA 10/2020 - 01/2017
4	EpitopesIBA 01/2020 - 05/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 12/2007
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 04/2024 - 09/2023
3	Immunoglobulin A (IgA)IBA 03/2024 - 12/2007
3	Long Noncoding RNAIBA 09/2023 - 04/2017
3	Therapeutic UsesIBA 04/2023 - 06/2017
3	InterleukinsIBA 01/2023 - 09/2015
3	EnzymesIBA 02/2022 - 01/2017
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 10/2015
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2016
3	Viral RNAIBA 01/2021 - 02/2014
3	Recombinant DNA (Recombinant DNA Research)IBA 01/2019 - 05/2014
2	COVID-19 VaccinesIBA 09/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	Interleukin-13IBA 01/2023 - 10/2015
2	Toll-Like Receptor 4IBA 01/2023 - 01/2017
2	NucleosidesIBA 01/2023 - 01/2022
2	mRNA VaccinesIBA 01/2023 - 01/2022
2	LipopolysaccharidesIBA 09/2022 - 01/2017
2	ImmunosorbentsIBA 02/2022 - 01/2017
2	HymecromoneIBA 02/2022 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 02/2022 - 01/2022
2	Codon (Codons)IBA 01/2022 - 01/2022
2	GP 140IBA 08/2021 - 06/2009
2	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 05/2003
2	LigandsIBA 11/2020 - 06/2017
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 01/2018
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2017 - 06/2017
2	Anti-Infective Agents (Microbicides)IBA 02/2016 - 01/2012
2	DermaVirIBA 01/2005 - 01/2005
1	Amino Acids FDA Link 03/2024
1	Asialoglycoprotein ReceptorIBA 02/2024
1	Small Interfering RNA (siRNA)IBA 02/2024
1	SuspensionsIBA 01/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023
1	P-selectin ligand proteinIBA 11/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 07/2023
1	thiazolyl blueIBA 07/2023

Therapy/Procedure

11	Immunotherapy 04/2024 - 01/2016
11	Therapeutics 11/2023 - 03/2002
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2014
1	Aftercare (After-Treatment) 02/2024
1	Parathyroidectomy 05/2023